|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 204.2 USD | +2.91% |
|
+0.54% | -10.17% |
| Apr. 29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
| Apr. 29 | US FDA publishes final rule for laboratory developed tests | RE |
Labcorp announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024, to stockholders of record as of the close of business on May 28, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.17% | 16.73B | |
| -14.58% | 84.68B | |
| +15.05% | 81.12B | |
| +10.49% | 29.59B | |
| -1.39% | 16.36B | |
| -31.58% | 11.77B | |
| +1.82% | 11.72B | |
| +31.86% | 11.71B | |
| -0.47% | 11.66B | |
| -8.00% | 11.37B |
LABORATORY CORPORATION OF AMERICA HOLDINGS 
